Stocktoria
ENANTA PHARMACEUTICALS INC ENTA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-03-21
ENANTA PHARMACEUTICALS INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Kowalsky Matthew Paul | Chief Legal Officer | 2026-02-12 | Grant | 1,318 | — |
| Kowalsky Matthew Paul | Chief Legal Officer | 2026-02-12 | Grant | 4,175 | — |
| Kowalsky Matthew Paul | Chief Legal Officer | 2026-02-12 | Tax withheld | 1,902 | $14.25 |
| Luu Brendan | Chief Business Officer | 2026-02-12 | Grant | 1,575 | — |
| Luu Brendan | Chief Business Officer | 2026-02-12 | Grant | 4,987 | — |
| Luu Brendan | Chief Business Officer | 2026-02-12 | Tax withheld | 3,257 | $14.25 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | 2026-02-12 | Grant | 1,575 | — |
| Kieffer Tara Lynn | Chief Product Strategy Officer | 2026-02-12 | Grant | 4,987 | — |
Source: SEC EDGAR filings · CIK 0001177648 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.